Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Bioorg Med Chem. 2010 Sep 20;18(21):7586–7592. doi: 10.1016/j.bmc.2010.08.045

Fig. 5.

Fig. 5

HDAC inhibition by TSA is dose dependent. Transformed yeast cells (see Figure 2) were grown without or with increasing concentrations of TSA and β-gal activity were measured quantitatively as described. Relative fold change in β-gal activity was calculated with respect to TSA-untreated cells and the mean fold change of four trials is shown with standard error (Table S3).